IL89872A - Use of 2-oxindole-1-carboxamides converted at position 3 to prepare boils to suppress T cell function - Google Patents

Use of 2-oxindole-1-carboxamides converted at position 3 to prepare boils to suppress T cell function

Info

Publication number
IL89872A
IL89872A IL8987289A IL8987289A IL89872A IL 89872 A IL89872 A IL 89872A IL 8987289 A IL8987289 A IL 8987289A IL 8987289 A IL8987289 A IL 8987289A IL 89872 A IL89872 A IL 89872A
Authority
IL
Israel
Prior art keywords
compound
pharmaceutically
acceptable base
base salt
formula
Prior art date
Application number
IL8987289A
Other languages
English (en)
Hebrew (he)
Other versions
IL89872A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL89872A0 publication Critical patent/IL89872A0/xx
Publication of IL89872A publication Critical patent/IL89872A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL8987289A 1988-04-13 1989-04-06 Use of 2-oxindole-1-carboxamides converted at position 3 to prepare boils to suppress T cell function IL89872A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/181,142 US4853409A (en) 1988-04-13 1988-04-13 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function

Publications (2)

Publication Number Publication Date
IL89872A0 IL89872A0 (en) 1989-12-15
IL89872A true IL89872A (en) 1994-06-24

Family

ID=22663072

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8987289A IL89872A (en) 1988-04-13 1989-04-06 Use of 2-oxindole-1-carboxamides converted at position 3 to prepare boils to suppress T cell function

Country Status (17)

Country Link
US (1) US4853409A (xx)
EP (1) EP0337628B1 (xx)
JP (1) JPH01311022A (xx)
KR (1) KR920002328B1 (xx)
AT (1) ATE89725T1 (xx)
AU (1) AU601326B2 (xx)
CA (1) CA1324762C (xx)
DE (1) DE68906707T2 (xx)
DK (1) DK174289A (xx)
HU (1) HU204996B (xx)
IE (1) IE62751B1 (xx)
IL (1) IL89872A (xx)
MY (1) MY103872A (xx)
NZ (1) NZ228712A (xx)
PH (1) PH25857A (xx)
PT (1) PT90249B (xx)
ZA (1) ZA892622B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111306C2 (de) * 1991-04-08 1994-06-01 Mack Chem Pharm Pharmazeutische Zubereitungen, die ein 2-Oxindol-l-carboxamid-derivat enthalten und zur Injektion bestimmt sind
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
DK0680321T3 (da) * 1993-01-22 1999-06-14 Pfizer Lysinsalt af 6-chlor-5-fluor-3-(2-thenoyl)-2-oxindol-1-carboxamid
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
US5545656A (en) * 1995-04-05 1996-08-13 Pfizer Inc. 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease
SK281254B6 (sk) * 1995-07-13 2001-01-18 Smithkline Beecham Corporation Použitie@kán-2-propánamínu, farmaceutický prostriedok s jeho obsahom a jeho použitie
AU7503496A (en) * 1995-12-19 1997-07-14 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
WO2006105796A1 (en) * 2005-04-08 2006-10-12 Leo Pharma A/S Novel indolinone derivatives
EP2886541A1 (en) * 2013-12-19 2015-06-24 Sanofi Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE3413572A1 (de) * 1984-04-11 1985-10-24 Hoechst Ag, 6230 Frankfurt Oxindol-verbindungen zur behandlung der epilepsie
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
AU6898287A (en) * 1986-01-30 1987-08-25 University Of Utah, The Treatment of bone loss
US5036099A (en) * 1987-02-02 1991-07-30 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Also Published As

Publication number Publication date
DE68906707D1 (de) 1993-07-01
MY103872A (en) 1993-09-30
HUT52376A (en) 1990-07-28
IL89872A0 (en) 1989-12-15
ZA892622B (en) 1990-11-28
PT90249A (pt) 1989-11-10
JPH01311022A (ja) 1989-12-15
EP0337628B1 (en) 1993-05-26
KR890015740A (ko) 1989-11-25
AU3271289A (en) 1989-10-19
AU601326B2 (en) 1990-09-06
KR920002328B1 (ko) 1992-03-21
HU204996B (en) 1992-03-30
PT90249B (pt) 1994-06-30
DE68906707T2 (de) 1993-09-16
ATE89725T1 (de) 1993-06-15
IE62751B1 (en) 1995-02-22
EP0337628A2 (en) 1989-10-18
EP0337628A3 (en) 1991-01-02
US4853409A (en) 1989-08-01
DK174289D0 (da) 1989-04-12
CA1324762C (en) 1993-11-30
PH25857A (en) 1991-12-02
NZ228712A (en) 1997-02-24
IE891171L (en) 1989-10-13
DK174289A (da) 1989-10-16

Similar Documents

Publication Publication Date Title
US4853409A (en) 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
US4794114A (en) Inhibition of interleukin-1 production by monocytes and/or macrophages
US4717716A (en) Immuno-regulator
CA1324761C (en) 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
CA2060789C (en) Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
KR20010021897A (ko) 건망증의 예방 또는 치료약
US5006547A (en) Tenidap as an inhibitor of the release of elastase by neutrophils
CA2335366A1 (en) Compositions and methods for treating elevated blood cholesterol
EP0425109B1 (en) 3-Substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis
RU2160102C2 (ru) Применение бензидамина для лечения патологических состояний, вызванных фно
IL92586A (en) History of 5-hydroxy and 5-methoxy-2-aminopyrimidines as inhibitors of interleukin-1 formation
CA1162856A (en) Aldose reductase inhibition by 1-(4-chlorobenzoyl)-5- methoxy-2-methyl-1h-indole-3-acetic acid
US5461072A (en) Use of aryl hydroxyurea compounds for the treatment of atherosclerosis
US4423060A (en) Aldose reductase inhibition by 1-methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetic acid
KR960703924A (ko) 항바이러스제로서 신규한 벤조티오펜 유사체(Novel Benzothiophene Analogs as Antiviral Agents)
US4361582A (en) Aldose reductase inhibition by γ-oxo-8-fluoranthenebutanoic acid
NZ235638A (en) The use of indole derivatives for treating interleukin-1 related disorders
CA2156120A1 (en) 3-substituted-2-oxindoles as inhibitors of viral replication

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees